vTv Therapeutics Inc. (Nasdaq:VTVT), a clinical-stage biopharmaceutical
company engaged in the discovery and development of new orally
administered treatments for Alzheimer’s disease and diabetes, today
announced that Stephen Holcombe, President and CEO and Dr. Larry
Altstiel, EVP, Chief Medical Officer, will present a corporate overview
at the 18th Annual BIO CEO & Investor Conference on Tuesday,
February 9, 2016 at 2:00pm EST. The conference will be held at The
Waldorf Astoria in New York City.
A live webcast of the presentation can be accessed on the News
& Events section of the website. The webcast will be archived
for 30 days following the presentation on the company website at www.vtvtherapeutics.com.
About vTv Therapeutics Inc.
vTv Therapeutics Inc. is a clinical-stage biopharmaceutical company
engaged in the discovery and development of orally administered small
molecule drug candidates to fill significant unmet medical needs. vTv
has a pipeline of clinical drug candidates led by programs for the
treatment of Alzheimer’s disease and Type 2 diabetes as well as
treatment of inflammatory disorders and the prevention of muscle
weakness.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160128005877/en/
Copyright Business Wire 2016